Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives

Movement Disorders

Volumn 30, Issue 13, 2015, Pages 1759-1766

  Baig, Fahd ^a   Lawton, Michael ^b   Rolinski, Michal ^a   Ruffmann, Claudio ^a   Nithi, Kannan ^a,c   Evetts, Samuel G ^a   Fernandes, Hugo R ^a   Ben Shlomo, Yoav ^a,b   Hu, Michele T M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NORTHAMPTON GENERAL HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

first degree relatives; nonmotor symptoms; Parkinson's disease; quality of life; treatment

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; FIRST DEGREE RELATIVE; GAIT DISORDER; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; PAIN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER; SYMPTOMATOLOGY; TREMOR; URINARY DYSFUNCTION; VERY ELDERLY;

EID: 84978468790     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26281     Document Type: Article

References (36)

1. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
2. Hely MA, Morris JG, Reid WG, et al. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-199.
3. Muller B, Assmus J, Herlofson K, et al. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. Parkinsonism Relat Disord 2013;19:1027-1032.
4. Hu M, Cooper J, Beamish R, et al. How well do we recognise non-motor symptoms in a British Parkinson's disease population? J Neurol 2011;258:1513-1517.
5. Zhang H, Gu Z, An J, et al. Non-motor symptoms in treated and untreated chinese patients with early Parkinson's disease. Tohoku J Exp Med 2014;232:129-136.
6. Erro R, Picillo M, Vitale C, et al. Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry 2012;84:14-17.
7. Muller B, Larsen JP, Wentzel-Larsen T, et al. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord 2011;26:65-72.
8. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80:276-281.
9. O'Sullivan SS, Williams DR, Gallagher DA, et al. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008;23:101-106.
10. Thacker EL, Ascherio A. Familial aggregation of Parkinson's disease: a meta-analysis. Mov Disord 2008;23:1174-1183.
11. Rolinski M, Szewczyk-Krolikowski K, Tomlinson PR, et al. REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease. J Neurol Neurosurg Psychiatry 2014;85:560-566.
12. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord 2014;20:99-105.
13. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical-diagnosis of idiopathic parkinsons-disease—a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
14. Hartfield EM, Fernandes HR, Vowles J, et al. Differentiation and characterisation of dopaminergic neurons derived from LRRK2 Parkinson's disease induced pluripotent stem cells. Soc Neurosci Abstr 2011;4 2:14631-14638.
15. Zokaei N, McNeill A, Proukakis C, et al. Visual short-term memory deficits associated with GBA mutation and Parkinson's disease. Brain 2014;137(Pt 8):2303-2311.
16. Stebbins GT, Goetz CG, Burn DJ, et al. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society Unified Parkinson's Disease Rating Scale: comparison with the Unified Parkinson's Disease Rating Scale. Mov Disord 2013;28:668-670.
17. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
18. Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923.
19. Trenkwalder C, Kohnen R, Hogl B, et al. Parkinson's disease sleep scale—validation of the revised version PDSS-2. Mov Disord 2011;26:644-652.
20. Muller B, Larsen JP, Wentzel-Larsen T, et al. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord 2011;26:65-72.
21. Guo X, Song W, Chen K, et al. Disease duration-related differences in non-motor symptoms: a study of 616 Chinese Parkinson's disease patients. J Neurol Sci 2013;330:32-37.
22. Dickson D, Fujishiro H, DelleDonne A, et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 2008;115:437-444.
23. Braak H, Del Tredici K. Invited article: Nervous system pathology in sporadic Parkinson disease. Neurology 2008;70:1916-1925.
24. Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD Study). Mov Disord 2015;30:229-237.
25. Lang AE. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 2011;26:775-783.
26. Shearer J, Green C, Counsell CE, et al. The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease. J Neurol 2011;259:462-468.
27. Lewis SJ, Foltynie T, Blackwell AD, et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-348.
28. Reijnders JS, Ehrt U, Lousberg R, et al. The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 2009;15:379-382.
29. Erro R, Vitale C, Amboni M, et al. The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS One 2013;8:e70244.
30. van Rooden SM, Colas F, Martinez-Martin P, et al. Clinical subtypes of Parkinson's disease. Mov Disord 2011;26:51-58.
31. van Rooden SM, Heiser WJ, Kok JN, et al. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 2010;25:969-978.
32. Kim HJ, Park SY, Cho YJ, et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 2009;287:200-204.
33. Mollenhauer B, Trautmann E, Sixel-Doring F, et al. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 2013;81:1226-1234.
34. Alves G, Muller B, Herlofson K, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009;80:851-857.
35. Elm JJ; NINDS NET-PD Investigators. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. Mov Disord 2012;27:1513-1521.
36. Parkinson Study Group. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol 1989;46:1052-1060.